32nd Issue, Date: 01st September 2022

Medi Beats
Dr. A. Muruganathan

Editor's Desk

Dr. A. Muruganathan

ArtificiaI Intelligence (AI) in Hypertension (HTN) Artificial Intelligence (AI) is an integration of computer science, data analytics, and pure mathematics, which enable computer systems to mimic human cognitive skills to simulate intelligent behavior and critical thinking comparable to a human being...

Read More

Guest Editorial

Dr. R. Rajasekar

Dr. R. Rajasekar, MD. FICP, FACP (USA), FRCP (Glasgow, Ireland, London &Edinburgh).
Senior Consultant Physician & Diabetologist - Kumbakonam

MY VIEWS ON MEDICAL CONDITIONS People may have different views on management of medical conditions. Let me share my observations, as a practicing...

Read More
Pearls for Practitioners

In Cardiology

Dr. Sangram S. Biradar Afib is a global epidemic. Afib affects men more than it does women it's more common in patients with...

Read More

In Diabetology

Dr. NK Singh Update Statin Induced New onset Diabetes: The available evidence supports that statins...

Read More

In Dermatology

Prof. Jayakar Thomas Graves disease is a syndrome characterized by hyperthyroidism, Graves ophthalmopathy...

Read More

In Endocrinology

Dr. Balachandran Sub Clinical Hyperthyroidism 40 years woman with follow up of TFT. She has diffuse goiter...

Read More
CTD-T

In Neurology

Dr. V. Balachandran Top 10 take-home messages for the management of patients with spontaneous intra-cerebral...

Read More

In Clinical Scenario

Dr. Meenakshi Bhattacharya Diagnostic criteria SLE- If ≥4 of the following criteria, well documented, are present at any time in a patient’s...

Read More
In Critical Care
Revelol-XL

Quiz Corner

Dr. R. Rajasekar 1. Hemiballismus is due to damage to?
Answer: Subthalamic nucleus...

Read More

History

Dr. M. Gowri Sankar A Tribute to the Visionary & the Father of Diabetology in India...

Read More
Glycinorm-M OD
Editorial Board
Conference And Events
Zerodol-SP

Disclaimer:

​We in the Editorial office wish to notify that we exclude ourselves from any adverse or any other unwelcome sequelae engendering from the various information or articles in this medi newsletter.
We wish all our readers a happy reading journey.

Letters to the Editor:

​Kindly send your feedback, questions, comments to themedibeats@gmail.com

For previous issues, please visit to our website www.medibeats.org

IPCA